Limitations, agreements, and source contact

Selinexor Treatment of Refractory Myeloma · Source last updated 2023-01-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

true

point Of Contact

email

jshah@karyopharm.com

organization

Karyopharm Therapeutics Inc.

phone

(617) 658-0600

title

Jatin Shah, MD

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice